Skip to main content
Publish date:

Millennium Selling Notes

It wants to raise $200 million.

Drugs manufacturer

Millennium Pharmaceuticals


filed a registration statement with the SEC indicating its intention to offer $200 million of convertible senior notes due Nov. 15, 2011.

TheStreet Recommends

The Cambridge, Mass.-based company expects to use the proceeds mainly for license arrangements and acquisitions.

This story was created through a joint venture between and IRIS.